Progress in the treatment of triple-negative breast cancer
Full article:

During the December 2023 San Antonio Breast Cancer Symposium, Dr. Melinda Telli presented a summary of research that has led to better treatments for triple-negative breast cancer (TNBC).  These treatments now include drugs called targeted therapies and immunotherapies for both early and late stages of TNBC. (Posted 3/19/24)

Questions To Ask Your Health Care Provider

Open Clinical Trials

The following are studies enrolling people with early-stage, TNBC.  

A number of other clinical trials for patients with early-stage TNBC can be found here.

The following are studies looking at new treatments for people with metastatic TNBC.  

A number of other clinical trials for treating patients with metastatic TNBC can be found here.


FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.